↓ Skip to main content

Medical Applications at CERN and the ENLIGHT Network

Overview of attention for article published in Frontiers in oncology, January 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
12 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Medical Applications at CERN and the ENLIGHT Network
Published in
Frontiers in oncology, January 2016
DOI 10.3389/fonc.2016.00009
Pubmed ID
Authors

Manjit Dosanjh, Manuela Cirilli, Steve Myers, Sparsh Navin

Abstract

State-of-the-art techniques derived from particle accelerators, detectors, and physics computing are routinely used in clinical practice and medical research centers: from imaging technologies to dedicated accelerators for cancer therapy and nuclear medicine, simulations, and data analytics. Principles of particle physics themselves are the foundation of a cutting edge radiotherapy technique for cancer treatment: hadron therapy. This article is an overview of the involvement of CERN, the European Organization for Nuclear Research, in medical applications, with specific focus on hadron therapy. It also presents the history, achievements, and future scientific goals of the European Network for Light Ion Hadron Therapy, whose co-ordination office is at CERN.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 29%
Professor > Associate Professor 2 12%
Student > Doctoral Student 1 6%
Student > Bachelor 1 6%
Lecturer 1 6%
Other 4 24%
Unknown 3 18%
Readers by discipline Count As %
Physics and Astronomy 7 41%
Nursing and Health Professions 2 12%
Medicine and Dentistry 2 12%
Social Sciences 1 6%
Engineering 1 6%
Other 0 0%
Unknown 4 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2024.
All research outputs
#3,372,144
of 25,927,633 outputs
Outputs from Frontiers in oncology
#960
of 22,839 outputs
Outputs of similar age
#54,994
of 408,018 outputs
Outputs of similar age from Frontiers in oncology
#10
of 83 outputs
Altmetric has tracked 25,927,633 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,839 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 408,018 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.